News

Harmless or lethal? Insilico Furthers Research on Fungal Infections

30 November 2009

Candida albicans is a harmless yeast fungus – at least most of the time. However, if the immune system is weak, then the fungus normally found on everyone’s skin and mucous membranes can become a lethal threat. Insilico Biotechnology is participating in a joint project funded by the German Federal Ministry of Education and Research (BMBF), in which interactions between fungus and human host cells are to be studied on the molecular level with the aim of developing new strategies for the prevention, diagnosis and therapy of fungal infections. infections. read more

Insilico joins industry collaboration on microbial genome research

30 December 2008

Insilico Biotechnology AG enters a consortium of leading companies in the chemicals, pharmaceuticals and nutrition industries pooling forces on microbial genome research. Industry and BMBF will provide around 600 million Euros for white biotechnology over the next decade. read more

Insilico is building in silico cells for Evonik Industries

28 November 2008

Insilico Biotechnology AG announces a multi-year collaboration with Evonik Industries, a global leader in systems-oriented development of industrial fermentations. The Stuttgart-based company provides its platform and expertise for building and simulating in silico bacterial strains. read more

Insilico expands collaboration with Kluyver Centre for Genomics of Industrial Fermentation

22 January 2008

Insilico Biotechnology AG announces a continued collaboration with the Netherlands’ Kluyver Centre, a joint industry and academic consortium that applies genomics technology for improving industrial fermentation. The Stuttgart based company provides its new steady state and dynamic modeling and simulation platform for the set-up and analysis of predictive metabolic network models. read more

Threefold Promotion: Insilico and BioIndustry 2021

17 October 2007

Insilico Biotechnology AG is partner in three out of five clusters belonging to the new research initiative entitled »BioIndustry 2021« which aims at meeting the oncoming challenges facing today’s society — first and foremost changes in climate followed by the ever increasing lack of resources — with innovative projects from the field of white biotechnology.

Insilico’s focus is on networking. Together with other partners from industry and research institutions, Insilico is playing an active role in BioIndustry 2021. The German Ministry of Education and Research (BMBF) is supporting this initiative with 60 million € in order to turn research ideas from the field of white biotechnology into products for marketing as soon as possible. The Ministry’s major goal here is to make Germany one of the most attractive sites in the world for biosciences. read more

Pages